AI Agents: Accelerants for drug discovery and commercialization
On November 12, 2025, the HSI lunchtime seminar series featured MIT Sloan alums Dr. Harison Hong, Executive Director and Brand Lead at Astria Therapeutics, and Tim Sun of Google’s Cloud AI GTM team, who discussed the role and impact of AI in the pharmaceutical industry development and sales cycles.
One speaker cited a McKinsey report that estimated that AI is poised to generate between $60 and $110 billion in annual value across the pharmaceutical value chain. AI can be applied to some of the most confounding challenges in discovery, clinical trials, and commercialization. The salient points of the wide-ranging conversation about AI applications are summarized in the PDF below.